Literature DB >> 1317572

Zinc finger point mutations within the WT1 gene in Wilms tumor patients.

M H Little1, J Prosser, A Condie, P J Smith, V Van Heyningen, N D Hastie.   

Abstract

A proposed Wilms tumor gene, WT1, which encodes a zinc finger protein, has previously been isolated from human chromosome 11p13. Chemical mismatch cleavage analysis was used to identify point mutations in the zinc finger region of this gene in a series of 32 Wilms tumors. Two exonic single base changes were detected. In zinc finger 3 of a bilateral Wilms tumor patient, a constitutional de novo C----T base change was found changing an arginine to a stop codon. One tumor from this patient showed allele loss leading to 11p hemizygosity of the abnormal allele. In zinc finger 2 of a sporadic Wilms tumor patient, a C----T base change resulted in an arginine to cysteine amino acid change. To our knowledge, a WT1 gene missense mutation has not been detected previously in a Wilms tumor. By comparison with a recent NMR and x-ray crystallographic analysis of an analogous zinc finger gene, early growth response gene 1 (EGR1), this amino acid change in WT1 occurs at a residue predicted to be critical for DNA binding capacity and site specificity. The detection of one nonsense point mutation and one missense WT1 gene point mutation adds to the accumulating evidence implicating this gene in a proportion of Wilms tumor patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1317572      PMCID: PMC49173          DOI: 10.1073/pnas.89.11.4791

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Mutation and cancer: a model for Wilms' tumor of the kidney.

Authors:  A G Knudson; L C Strong
Journal:  J Natl Cancer Inst       Date:  1972-02       Impact factor: 13.506

2.  Sequence-specific DNA-binding activities of the gap proteins encoded by hunchback and Krüppel in Drosophila.

Authors:  D Stanojević; T Hoey; M Levine
Journal:  Nature       Date:  1989-09-28       Impact factor: 49.962

3.  Molecular nature of genetic changes resulting in loss of heterozygosity of chromosome 11 in Wilms' tumours.

Authors:  M Mannens; R M Slater; C Heyting; J Bliek; J de Kraker; N Coad; P de Pagter-Holthuizen; P L Pearson
Journal:  Hum Genet       Date:  1988-12       Impact factor: 4.132

4.  Familial predisposition to Wilms' tumour does not map to the short arm of chromosome 11.

Authors:  P Grundy; A Koufos; K Morgan; F P Li; A T Meadows; W K Cavenee
Journal:  Nature       Date:  1988-11-24       Impact factor: 49.962

5.  The candidate Wilms' tumour gene is involved in genitourinary development.

Authors:  K Pritchard-Jones; S Fleming; D Davidson; W Bickmore; D Porteous; C Gosden; J Bard; A Buckler; J Pelletier; D Housman
Journal:  Nature       Date:  1990-07-12       Impact factor: 49.962

6.  Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome.

Authors:  J Pelletier; W Bruening; C E Kashtan; S M Mauer; J C Manivel; J E Striegel; D C Houghton; C Junien; R Habib; L Fouser
Journal:  Cell       Date:  1991-10-18       Impact factor: 41.582

7.  WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour.

Authors:  J Pelletier; W Bruening; F P Li; D A Haber; T Glaser; D E Housman
Journal:  Nature       Date:  1991-10-03       Impact factor: 49.962

8.  Nonrandom loss of maternal chromosome 11 alleles in Wilms tumors.

Authors:  W T Schroeder; L Y Chao; D D Dao; L C Strong; S Pathak; V Riccardi; W H Lewis; G F Saunders
Journal:  Am J Hum Genet       Date:  1987-05       Impact factor: 11.025

9.  Structural rearrangements of the WT1 gene in Wilms' tumour cells.

Authors:  J K Cowell; R B Wadey; D A Haber; K M Call; D E Housman; J Pritchard
Journal:  Oncogene       Date:  1991-04       Impact factor: 9.867

10.  Parental origin of de novo constitutional deletions of chromosomal band 11p13.

Authors:  V Huff; A Meadows; V M Riccardi; L C Strong; G F Saunders
Journal:  Am J Hum Genet       Date:  1990-07       Impact factor: 11.025

View more
  35 in total

1.  Inhibition of cellular proliferation by the Wilms tumor suppressor WT1 requires association with the inducible chaperone Hsp70.

Authors:  S Maheswaran; C Englert; G Zheng; S B Lee; J Wong; D P Harkin; J Bean; R Ezzell; A J Garvin; R T McCluskey; J A DeCaprio; D A Haber
Journal:  Genes Dev       Date:  1998-04-15       Impact factor: 11.361

2.  Correlation of germ-line mutations and two-hit inactivation of the WT1 gene with Wilms tumors of stromal-predominant histology.

Authors:  V Schumacher; S Schneider; A Figge; G Wildhardt; D Harms; D Schmidt; A Weirich; R Ludwig; B Royer-Pokora
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

3.  Regulation of insulin-like growth factor I receptor gene expression by the Wilms' tumor suppressor WT1.

Authors:  H Werner; C T Roberts; F J Rauscher; D LeRoith
Journal:  J Mol Neurosci       Date:  1996       Impact factor: 3.444

4.  Antagonism of WT1 activity by protein self-association.

Authors:  P Moffett; W Bruening; H Nakagama; N Bardeesy; D Housman; D E Housman; J Pelletier
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

5.  Uniparental disomy occurs infrequently in Wilms tumor patients.

Authors:  P Grundy; B Wilson; P Telzerow; W Zhou; M C Paterson
Journal:  Am J Hum Genet       Date:  1994-02       Impact factor: 11.025

6.  Fine structure analysis of the WT1 gene in sporadic Wilms tumors.

Authors:  R Varanasi; N Bardeesy; M Ghahremani; M J Petruzzi; N Nowak; M A Adam; P Grundy; T B Shows; J Pelletier
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

7.  Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms tumor suppressor WT1.

Authors:  A L Gashler; D T Bonthron; S L Madden; F J Rauscher; T Collins; V P Sukhatme
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

8.  Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product.

Authors:  H Werner; G G Re; I A Drummond; V P Sukhatme; F J Rauscher; D A Sens; A J Garvin; D LeRoith; C T Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

9.  Exon skipping due to a mutation in a donor splice site in the WT-1 gene is associated with Wilms' tumor and severe genital malformations.

Authors:  S Schneider; G Wildhardt; R Ludwig; B Royer-Pokora
Journal:  Hum Genet       Date:  1993-07       Impact factor: 4.132

10.  Analysis of the tumour suppressor genes, FHIT and WT-1, and the tumour rejection genes, BAGE, GAGE-1/2, HAGE, MAGE-1, and MAGE-3, in benign and malignant neoplasms of the salivary glands.

Authors:  H Nagel; R Laskawi; H Eiffert; T Schlott
Journal:  Mol Pathol       Date:  2003-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.